SS Innovations International, Inc. (Nasdaq: SSII) announced on November 19, 2026, that a team of surgeons successfully performed the world's first dual-console, beating-heart Totally Endoscopic Coronary Artery Bypass (TECAB) surgery. The procedure utilized all five arms of the Company’s SSi Mantra surgical robotic system and was conducted at Medanta - The Medicity Hospital in Gurugram, India.

The surgery was performed by Dr. Nitin Kumar Rajput of Medanta Hospital and Dr. Lalit Malik of Manipal Hospital, Jaipur, under the guidance of Dr. Sudhir Srivastava, the Company’s Chairman and Chief Executive Officer. The team used two separate consoles to control the SSi Mantra, completing the complex cardiac procedure with all five robotic arms operating simultaneously and in synchronization. A heart stabilization system was used to steady the target area while the patient's heart continued to beat, without the use of a heart-lung machine.

TECAB is a minimally invasive coronary artery bypass procedure performed through small incisions without opening the chest. The Company stated that this combination of a beating-heart approach with a five-arm robotic configuration under dual-console control represents a significant advancement in robotic cardiac surgery.

Dr. Sudhir Srivastava commented that the successful use of dual-console control and five robotic arms demonstrates the advanced capabilities of the SSi Mantra in enabling complex minimally invasive cardiac surgeries. Dr. Naresh Trehan, Chairman and Managing Director of Medanta Hospital, stated that the patient is doing extremely well and that the innovation has transformed the way robotic surgery will be performed in the future.

The SSi Mantra system is a modular, multi-arm system capable of supporting 3 to 5 robotic arms. It features an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and a touch-panel monitor for displaying patient information. The system has been clinically validated in India in more than 190 different types of surgical procedures.